检索

标题
作者
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E., Dudnikova A.
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V., Shamkhalova M., Duganova A.
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases
Fomin V., Pulin A., Mukhin N.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2
Arutiunov G., Tarlovskaia E., Koziolova N., Boldina M., Batiushin M., Ametov A., Arutiunov A., Belevskii A., Galstian G., Grigor’eva N., Dzhunusbekova G., Esaian A., Mal’chikova S., Mit’kovskaia N., Mkrtumian A., Orlova I., Petrova M., Rebrov A., Ruzanov D., Salukhov V., Sisakian A., Skibitskii V., Sugraliev A., Fomin I., Khalimov I., Chesnikova A., Shaposhnik I., Shestakova M.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Oshchepkova E., Dmitriev V., Titov V.
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease
Moiseev S., Karovaikina E., Bulanov N., Moiseev A., Fomin V.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O., Martynov A., Arutyunov G., Bakulin I., Livzan M., Maev I., Egorov I.
Motivation for treatment in patients with chronic cardiorenal syndrome
Efremova E., Shutov A., Borodulina E.
Epidemiology of chronic renal disease in the Northwest of Russia: setting-up the register
Dobronravov V., Smirnov A., Dragunov S., Zverkov R., Evdokimova T., Butrimova S., Grigorschuk V.
Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease
Taranova M., Milovanova L., Kozlovskaya(Lysenko) L., Milovanova S., Androsova T., Zubacheva D., Lebedeva M., Dobrosmyslov I., Kozlov V., Kuchieva A., Li O., Reshetnikov V.
Nutritional support for patients with chronic kidney disease at pre-dialysis stages
Kuzmina A.
Nephrological aspects of surgical weight correction in morbid obesity
Bobkova I., Gussaova S., Stavrovskaya E., Struve A.
Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum
Mukhin N., Glybochko P., Svistunov A., Fomin V., Kiyakbaev G.
Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease
Vasilyeva M., Rudenko T., Kutyrina I., Solomakhina N.
Effect of eprosartan on the hemostatic system in patients with chronic kidney disease associated with hereditary thrombophilia
Kaliuzhin V., Sibireva O., Urazova O., Tkalich L., Zibnitskaia L., Kaliuzhina E., Sazonov É., Grankina V.
The level of endothelin-1 and reactivity of skin microvessels in patients with early stages of chronic kidney disease
Smirnov A., Petrishchev N., Panina I., Mnuskina M., Achkasova V., Rumyantsev A., Menshutina M., Smirnov A., Petrischev N., Panina I., Mnuskina M., Achkasova V., Rumyantsev A., Menshutina M.
Current challenges for therapy of comorbid patients: a new look at celecoxib. A review
Zyryanov S., Baybulatova E.
The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease
Mikhailova N.
Polyvascular disease in patients with myocardial infarction and chronic kidney disease
Karetnikova V., Kalaeva V., Evseeva M., Gruzdeva O., Zykov M., Kashtalap V., Barbarash O.
Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery
Gussaova S., Bobkova I., Yashkov Y., Bordan N., Stavrovskaya E., Bekuzarov D., Evdoshenko V., Fedenko V., Malykhina A., Struve A.
Glycemic control in patients with diabetes mellitus on hemodialysis
Lobanova K., Severina A., Martinov S., Shamkhalova M., Shestakova M.
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
Mukhin N., Milovanov Y., Kozlovskaya L., Dobrosmyslov I., Milovanova L.
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
Milovanova L., Milovanov Y., Kudryavtseva D., Markina M., Milovanova S., Kozlovskaya L., Lebedeva M., Beketov V., Moiseev S., Mukhin N., Fomin V., Svistunov A.
Chronic kidney disease and vascular dementia
Mukhin N., Fomin V., Damulin I., Rogova I.
Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity
Galliamov M., Saginova E., Severova M., Samokhodskaia L., Krasnova T., Sholomova V., Sorokin I., Mukhin N.
Hyperuricemia as a component of cardiorenal syndrome
Mukhin N., Fomin V., Lebedeva M., Mukhin N., Fomin V., Lebedeva M.
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
Kotenko O., Abolyan L., Kuteinikov V., Vinogradov V., Fomin V.
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study
Batyushin M.
Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2–5D
Milovanova L., Lysenko (Kozlovskaya) L., Milovanova S., Taranova M., Kozlov V., Reshetnikov V., Lebedeva M., Androsova T., Zubacheva D., Chebotareva N.
Normoalbuminuric chronic kidney disease in diabetes
Klimontov V., Korbut A.
Acute glomerulonephritis in the 21st century
Mukhin N., Glybochko P., Svistunov A., Fomin V., Shilov E., Lysenko L.
Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
Gracheva S., Biragova M., Glazunova A., Klefortova I., Shamkhalova M., Dzhavelidze M., Soldatova T., Il'in A., Shestakova M., Tugeeva É., Buziashvili I.
Risk factors for cardiovascular system damage in chronic kidney disease
Kutyrina I., Rudenko T., Savel'eva S., Shvetsov M., Vasil'eva M.
Specific features of cognitive impairments in patients with predialysis chronic kidney disease
Rogova I., Fomin V., Damulin I., Shashkova E.
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE)
Nikolaev A.
The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys
Milovanov Y., Kozlovskaya L., Milovanova L., Milovanov Y., Kozlovskaya L., Milovanova L.
Calcium antagonists: on the way to expanding the indications
Fomin V.
Low protein diet with essential amino acids ketoanalogues combination can affect serum FGF-23 and Klotho levels in chronic kidney disease 3b-4 stages patients: randomized pilot study
Milovanova L., Kozlovskaya(Lysenko) L., Androsova T., Lebedeva M., Taranova M., Milovanova S., Kondratyeva T., Zubacheva D., Tchebotareva N., Kozlov V., Kuchieva A., Li O., Reshetnikov V.
Anticoagulant therapy in patients with atrial fibrillation and reduced kidney function of diabetic and non-diabetic etiologies
Sokolova A., Daabul I., Tsarev I., Napalkov D., Fomin V.
Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression
Shvetsov M., Zheng A., Kozlovskaya L., Serova A., Travkina E., Mukhin N.
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
Pulin A., Kustova T., Fomin V., Mukhin N.
LONG-ACTING ERYTHROPOETIN EFFICACY IN THE TREATMENT OF NEPHROGENIC ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT A PREDIALYSIS STAGE
Milovanov Y., Milovanova L.
Obesity and chronic kidney disease
Bondar' I., Klimontov V., Simakova A., Bondar I., Klimontov V., Simakova A.
Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho
Milovanova L., Kozlovskaya L., Milovanov Y., Bobkova I., Dobrosmyslov I.
Correlations between the levels of vitamin D, parathormone, calcium, blood phosphates in patients with chronic disease of the kidneys untreated with replacement renal therapy
Smirnov A., Volkov M., Galkina O., Zhloba A., Emanuel' V., Smirnov A., Volkov M., Galkina O., Zhloba A., Emanel V.
State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review
Bulanov N., Moiseev S.
Venous thromboembolic complications in patients with chronic kidney disease: prevalence and features of drug treatment
Dzhioeva O., Orlova A., Rogozhkina E., Drapkina O.
Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease
Rudenko T., Kamyshova E., Vasilyeva M., Bobkova I., Solomakhina N., Shvetsov M.
Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease
Dzgoeva F., Sopoev M., Gatagonova T., Bestaeva T., Khamitsaeva O.
Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
Dzgoeva F., Gatagonova T., Bestaeva T., Sopoev M., Bazaeva B., Khamitsaeva O.
Renal anemia and cardiac remodeling in patient with chronic glomerulonephritis
Murkamilov I., Lunegova O., Kaliev R.
New markers of cardio-renal links in chronic kidney disease
Milovanova L., Milovanov I., Kozlovskaia L., Mukhin N.
Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease
Musina N., Semenova R.
THE ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME
Kutyrina I., Kryachkova A., Savelieva S.
Treatment of diabetes mellitus in dialysis patients
Bondar' I., Klimontov V., Bondar I., Klimontov V.
The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients
Saginova E., Gallyamov M., Severova M., Surkova O., Fomin V., Ermakov N., Rodina A., Mukhin N., Saginova E., Gallyamov M., Severova M., Surkova O., Fomin V., Ermakov N., Rodina A., Mukhin N.
Autonomic imbalance in patients with metabolic syndrome: role in the development of hyperfiltration, an early marker of renal lesion
Gornostayeva E., Novikova M., Beloborodova A., Akarachkova E., Shilov E., Shvarkov S.
Chronic kidney disease and chronic heart failure: impact on prognosis and choice of pathogenetic therapy
Mezhonov E., Reitblat O., Vyalkina Y., Airapetian A., Lazareva N., Ageev F., Blankova Z., Svirida O., Prints Y., Zhirov I., Tereshchenko S., Boytsov S.
Effect of vitamin D receptor activators on serum Klotho levels in 3b–4 stages chronic кidney disease patients: a prospective randomized study
Milovanova L., Beketov V., Milovanova S., Taranova M., Kozlov V., Pasechnik A., Reshetnikov V., Androsova T., Kalashnikov M.
Chronic kidney disease in rheumatoid arthritis patients: prevalence, risks factors, histopathological variants
Chebotareva N., Guliaev S., Androsova T., Milivanova L.
Role of free radical oxidation in the development of cardiovascular events in chronic renal failure
Dzgoeva F., Gatagonova T., Dzugkoeva F., Kochisova Z., Kadzaeva Z., Khamitsaeva O., Dzgoyeva F., Gatagonova T., Dzugkoyeva F., Kochisova Z., Kadzayeva Z., Khamitsayeva O.
Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease
Rudenko T., Vasilyeva M., Solomakhina N., Kutyrina I.
Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease
Milovanova L., Dobrosmyslov I., Milovanov I.
Phosphate binders in chronic kidney disease: The positions of sevelamer
Fomin V., Shilov E., Svistunov A., Milovanov I.
The role of major vessels remodeling in development of left ventricular hypertrophy in patients with a predialysis stage of chronic renal failure
Kutyrina I., Rudenko T., Shvetsov M., Kushnir V.
Cardiorenal syndromes: historical aspects and current challenges
Nezhdanov K., Milovanova L., Strizhakov L., Krasnova T.
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
Shamkhalova M., Sukhareva O., Shestakova M.
Pentoxifylline and nephroprotection: effects on renal dysfunction and cardiovascular risks
Murkamilov I., Aitbaev K., Fomin V., Murkamilova Z., Bayzhigitova A.
Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
Arutyunova M., Glazunova A., Mikhaleva O., Zuraeva Z., Martynov S., Klefortova I., Manchenko O., Ulyanova I., Ilyin A., Shamkhalova M., Shestakova M.
Prognostic value of renal resistance index in estimating the progression of chronic kidney disease
Gazhonova V., Zykova A., Chistyakov A., Roshchupkina S., Romanova M., Krasnova T.
Hyperfiltration is an early sign of evolving chronic renal disease in males with metabolic syndrome
Novikova M., Shilov E., Borisov V., Novikova M., Shilov E., Borisov V.
End products of glycation (AGEs) and inflammation in the clinic of cardiovascular complications and vascular calcification at different stages of chronic kidney disease (G1–G5D)
Fatima D., Remizov O., Ikoeva Z., Tedeeva I., Gusalov A., Goloeva V.
Frailty and chronic kidney disease – the real problem of modern nephrology: A review
Rudenko T., Bobkova I., Kamyshova E., Stavrovskaya E.
The relationship of hypertriglyceridemia and left ventricular remodeling types in patients with chronic kidney disease
Murkamilov I., Sabirov I., Fomin V., Aitbaev K., Murkamilova Z.
Chronic kidney disease as a multidisciplinary problem of contemporary medicine
Podzolkov V., Bragina A.
Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection
Milovanov Y., Mukhin N., Kozlovskaya L., Milovanova S., Markina M.
Efficiency and safety of lipid-lowering therapy for chronic kidney disease
Kolina I., Stavrovskaia E.
ENDOTHELIAL DYSFUNCTION AND APOPTOSIS AT EARLY STAGE OF CHRONIC KIDNEY DISEASE
Smirnov A., Petrischev N., Mnuskina M., Panina I., Pumyantsev A., Vasina E., Achkasova V., Menshutina M.
Current methods for measuring the glomerular filtration rate in persons with normal weight and overweight
Novikova M., Kutyrina I., Shilov E., Novikova M., Kutyrina I., Shilov E.
Nephroprotective role of early correction of impaired nutritional status in patients with chronic disease of the kidneys at a predialysis stage
Milovanov I., Kozlovskaia L., Milovanova L.
1 - 83 的 83 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».